News

International Seminar on Cancer Policies in South America

In Santiago, Chile, on April 22, 2015, The Chilean Health Ministry (MINSAL) organized a seminar to discuss regional policies for cancer prevention and control. Representatives of WHO, OPS, RINC, and UNASUR, were invited along [...]

By |2019-04-08T10:24:18-04:00May 7th, 2015|Advocacy, News|

Importance of Therapeutic Drug Monitoring for Targeted Therapies

As personalized medicine has become an accepted paradigm, it may be time for oncologists to examine personalized dose levels.In a recent article from Cancer World, the author explores the value of therapeutic drug monitoring for [...]

By |2019-04-08T10:18:30-04:00May 1st, 2015|Drug Treatment, News|

Blueprint Medicines Presents Preclinical Data on BLU-285

Blueprint Medicines presented new preclinical data on its drug candidate, BLU-285, and its potential value in  treatment-resistant GIST and on novel cancer drug targets at the AACR (American Association for Cancer Research) Annual Meeting [...]

By |2019-04-08T10:13:47-04:00April 24th, 2015|D842V, News, Research|

Fatigue Reduction: Moving Towards a Better Future

As one of the most common side-effects of Gleevec, Sutent and Stivarga, fatigue is a condition that many GIST survivors are intimately acquainted with. The National Comprehensive Cancer Network defines cancer-related fatigue as “a [...]

By |2022-01-05T11:13:27-05:00April 7th, 2015|News, Side Effects|
Go to Top